Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)
- 5 March 2013
- journal article
- Published by Springer Nature in International Journal of Hematology
- Vol. 97 (4) , 465-471
Abstract
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of B cell lymphomas. MicroRNA expression provides a new and interesting tool for understanding the biology and clinical course of DLBCL. The present study presents microRNA-129-5p expression data from DLBCL patients treated with CHOP or R-CHOP. Patients with low microRNA-129-5p expression had a median survival of 23 months and a significantly shorter overall survival (P = 0.0042) compared to patients with high microRNA-129-5p expression, who had a median survival of 58 months. We also found that patients treated with R-CHOP only and displaying low microRNA-129-5p expression had a significantly shorter overall survival compared to patients with high microRNA-129-5p expression; all such patients were still alive at the time of last follow-up (P = 0.043). No significant difference was found among microRNA-129-5p expression in tumor tissue, the tissue surrounding the tumor, and normal controls. To our knowledge, this is the first report to show that the expression of microRNA-129-5p can affect the clinical outcome of DLBCL patients and that microRNA-129-5p may be involved in the biology of DLBCL development, although larger studies are necessary to confirm this. Further investigations may also help to elucidate the biological role of microRNA-129-5p in DLBCL.Keywords
This publication has 34 references indexed in Scilit:
- miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapyBlood, 2011
- Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancerInternational Journal of Cancer, 2011
- Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial CancerCancer Research, 2009
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High AccuracyClinical Cancer Research, 2009
- Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphomaJournal of Cellular and Molecular Medicine, 2009
- Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitroCancer Research, 2009
- Biogenesis of small RNAs in animalsNature Reviews Molecular Cell Biology, 2009
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- microRNA expression profile in undifferentiated gastric cancerInternational Journal of Oncology, 1992